Thermo Fisher Expands Clinical and Commercial Capabilities for Plasmid DNA Manufacturing December 16, 2020December 18, 2020 by / Share This.....LinkedinTwitterFacebookGoogleEmailNew Carlsbad, California cGMP site will accelerate commercialization of plasmid-based medicines and vaccines Related News: Opening Ceremony Held for New Building at The…GE Healthcare Introduces An Industry-First Modular,…GE Healthcare Introduces An Industry-First Modular,…GE Healthcare Introduces An Industry-First Modular,…Telix Partnership Expands GE Healthcare…Thermo Fisher Scientific Selects Mebane, N.C. as…
